Promoter holding
64.27%
LT
Lexine Technochem Private Limited - Due diligence report
A 360° intelligence report on Lexine Technochem Private Limited: trust score, financial health, credit view, compliance, directors, growth a…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Lexine Technochem Private Limited — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Lexine Technochem Private Limited is assessed as Low Risk with a Trust Score of 85/100. Lexine Technochem Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Lexine Technochem Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 4 open (16.00 cr) · 5 satisfied (4.59 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
| Sidbi | 3 | 48.0 cr |
| Indian Bank | 3 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| The Mehsana Urban Co-Operative Bank Limited | 1 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MANOJ KANAIYALAL SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AKHIL MANOJKUMAR SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Akhil Healthcare Private Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Akhil Healthcare Private Limited | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 55 · Distress 75
Growth signals & trust indicators
EPFO headcount growing - hiring signal.
Operating for 16+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
4 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 4 open charge(s) of 16.00 cr already registered.
- Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
26 Aug 2025
Charge created
Others - 10.00 cr
21 Aug 2025
Charge satisfied
Indian Bank
31 Mar 2025
Latest balance sheet
Filed with ROC
13 Mar 2025
Charge satisfied
Indian Bank
20 Mar 2024
Charge created
Sidbi - 2.00 cr
12 May 2022
Charge created
Sidbi - 2.00 cr
29 Dec 2021
Charge created
Indian Bank - 16.40 Lakh
17 Jun 2021
Charge created
Sidbi - 2.00 cr
31 Mar 2021
Securities allotted
1040816 Equity Shares - 2.08 cr raised
01 Jul 2020
Charge created
Indian Bank - 32.93 Lakh
31 Mar 2019
Securities allotted
990000 Equity Shares - 99.00 Lakh raised
27 Sep 2016
Charge satisfied
Hdfc Bank Limited
17 Sep 2016
Charge created
Indian Bank - 3.60 cr
28 Jan 2015
Charge satisfied
The Mehsana Urban Co-Operative Bank Limited
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Moraya Global Limited | U24110MH1994PLC076214 | Mumbai, Maharashtra, India |
| Ridley Life Science Private Limited | U24232DL2004PTC129295 | Delhi, Delhi, India |
| Marine Medicare Private Limited | U24304HP2020PTC007769 | Solan, Himachal Pradesh, India |
| Relief Biotech Private Limited | U24232UR2005PTC010259 | Roorkee, Uttarakhand, India |
| Ronald Pharmaceutical | U24110GJ1993PTC019347 | Baroda, Gujarat, India |
| Brassica Pharma Private Limited | U24230MH2006PTC160053 | Mumbai, Maharashtra, India |
| Krushinath Green Energy Limited | U15421PN2012PLC142602 | Pune, Maharashtra, India |
| Casper Pharma | U24233MH2016PTC423891 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Lexine Technochem Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Lexine Technochem Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Lexine Technochem Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Lexine Technochem Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Lexine Technochem Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Lexine Technochem Private Limited an active company?
Lexine Technochem Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Lexine Technochem Private Limited financially healthy?
Lexine Technochem Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Lexine Technochem Private Limited?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Lexine Technochem Private Limited?
The ultimate holding entity is Akhil Healthcare Private Limited. 2 active director(s) are on record.
Does Lexine Technochem Private Limited have loans or charges against its assets?
4 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Lexine Technochem Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Lexine Technochem Private Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
